WeInfuse and Trial IQ Partner to Integrate AI Clinical Research Tools for Infusion Providers

June 02, 2026
WeInfuse has announced a partnership with Trial IQ Technologies to integrate AI tools that help infusion providers launch and manage clinical trial programs, expanding access to research within community care settings.

WeInfuse has announced a partnership with Trial IQ Technologies to integrate clinical research capabilities into infusion centers, according to a press release. The collaboration aims to help infusion providers launch and manage clinical trial programs using automation and AI tools.

The integration will allow WeInfuse users to access operational workflows and infrastructure that support clinical research within existing infusion operations. Trial IQ’s software automates trial matching, patient identification, site readiness, and physician education, enabling providers to become research ready with minimal disruption.

Through the partnership, infusion centers can embed research functions directly into their care environments, expanding access to clinical trials and new therapies. The combined platform is available to both current and future WeInfuse clients seeking to add clinical research services to their operations.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Enterprise AI Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Enterprise

06/02
American Diabetes Association Invests in UpDoc for AI Chronic Care Platform
06/02
OpsGuru Named Launch Partner for AWS Partner Innovation Hub in Toronto
06/02
Recorded Future and Wipro Partner on AI Threat Intelligence Services
06/02
Cognizant and CrowdStrike Expand Partnership to Secure Enterprise AI
06/02
Mayo Clinic and Microsoft Develop Frontier AI Model for Healthcare

More from: Life Sciences

06/02
American Diabetes Association Invests in UpDoc for AI Chronic Care Platform
06/02
Mayo Clinic and Microsoft Develop Frontier AI Model for Healthcare
06/02
Pathwork Launches Broker Access to Medical and Prescription Data
06/02
Acclinate and HCN Global Partner to Expand Clinical Research Access for Hispanic and Latino Communities
06/02
Cortechs.ai and Microsoft Integrate AI Imaging Tools into Radiology Workflows

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You May Also Like